Wells Fargo’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Wells Fargo’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-69,934	Closed	-$466K	–	7744
2023 Q3	$466K	Sell	69,934 -4,424	-6%	-$36.8K	﹤0.01%	3832
2023 Q2	$674K	Buy	74,358 +22,328	+43%	+$197K	﹤0.01%	3738
2023 Q1	$378K	Buy	52,030 +45,030	+643%	+$334K	﹤0.01%	4030
2022 Q4	$51K	Sell	7,000 -2,164	-24%	-$16.1K	﹤0.01%	4845
2022 Q3	$70K	Sell	9,164 -434	-5%	-$3.68K	﹤0.01%	4802
2022 Q2	$66K	Buy	9,598 +2,149	+29%	+$16.4K	﹤0.01%	4887
2022 Q1	$60K	Buy	7,449 +1	+0%	+$6	﹤0.01%	5567
2021 Q4	$42K	Buy	7,448 +1	+0%	+$8	﹤0.01%	6054
2021 Q3	$57K	Buy	+7,447	New	+$67.9K	﹤0.01%	5578
2021 Q1	–	Sell	-2,000	Closed	-$28K	–	7572
2020 Q4	$28K	Buy	+2,000	New	+$27.8K	﹤0.01%	5769

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Wells Fargo's PNT Position: Q4 2023 in Review

Wells Fargo sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 69,934 shares — an estimated $466K sold.

Wells Fargo first reported a position in PNT in Q4 2020 and held it in 10 quarters. The position peaked at $674K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Wells Fargo reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Wells Fargo sold 69,934 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $466K.
Wells Fargo first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2020 and held it in 10 quarters.
Wells Fargo's POINT Biopharma Global Inc. Common Stock position peaked at $674K in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.